OWIM
NVS icon

Old West Investment Management’s Novartis NVS Stock Holding History

Old West Investment Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-11,845
Closed -$750K – 82
2013
Q2 		$750K Buy
+11,845
New +$771K 0.37% 51

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Old West Investment Management's NVS Position: Q3 2013 in Review

Old West Investment Management sold out of Novartis (NVS) in Q3 2013, closing a stake of 11,845 shares — an estimated $750K sold.

Old West Investment Management first reported a position in NVS in Q2 2013 and held it in 1 quarter. The position peaked at $750K in Q2 2013. 761 funds tracked by Wall St. Rank hold NVS as of Q3 2013.

  • Old West Investment Management reported no remaining Novartis position as of Q3 2013 after selling out during the quarter.
  • Old West Investment Management sold 11,845 Novartis shares in Q3 2013, an estimated $750K.
  • Old West Investment Management first reported a position in Novartis in Q2 2013 and held it in 1 quarter.
  • Old West Investment Management's Novartis position peaked at $750K in Q2 2013.
  • 761 funds tracked by Wall St. Rank held Novartis as of Q3 2013.

Based on Old West Investment Management's 13F filing for Q3 2013, filed 14 Nov 2013.